2.Clinical studies on the chemotherapy in advanced oral cancer patients.
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1993;19(1):12-21
No abstract available.
Drug Therapy*
;
Humans
;
Mouth Neoplasms*
3.Clinical studies on the chemotherapy in advanced oral cancer patients.
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1993;19(1):12-21
No abstract available.
Drug Therapy*
;
Humans
;
Mouth Neoplasms*
5.Dermoid cyst in the floor of the mouth with tongue fistula: a case report.
Pingfan WU ; Zhenge LEI ; Jian WU ; Linlin CHEN
West China Journal of Stomatology 2015;33(6):663-664
Dermoid cysts in the floor of the mouth with tongue fistula are unusual lesions. This study reported a case of dermoid cyst in the floor of the mouth with tongue fistula, analyzed the causes of such formation, and discussed the appropriate diagnosis and treatment methods by reviewing relevant literature.
Dermoid Cyst
;
complications
;
diagnosis
;
therapy
;
Fistula
;
complications
;
Humans
;
Mouth Floor
;
Mouth Neoplasms
;
complications
;
diagnosis
;
therapy
;
Tongue
7.Development of oral and maxillofacial oncology in China.
Chinese Medical Journal 2003;116(10):1567-1573
China
;
Facial Neoplasms
;
therapy
;
Humans
;
Maxillary Neoplasms
;
therapy
;
Medical Oncology
;
trends
;
Mouth Neoplasms
;
therapy
8.Influence of thermochemotherapy on the activity of cytotoxic T lymphocyte in oral maxillofacial cancer patients.
Jun GUO ; Chang-jie MEN ; Sheng-zhi WANG ; Xiang-dong GAO ; Zhou CHENG ; Zu-yi MAO ; Da-zhang WANG
West China Journal of Stomatology 2007;25(5):441-443
OBJECTIVETo study the influence of thermochemotherapy on the activity of cytotoxic T lymphocyte (CTL) in peripheral blood of patients with oral maxillofacial cancer.
METHODSTwenty-one subjects with oral maxillofacial cancer were treated by thermochemotherapy, and the activity of CTL in peripheral blood was analyzed.
RESULTSThermochemotherapy can obviously enhance the activity of CTL (P<0.01).
CONCLUSIONThermochemotherapy can enhance the activity of CTL, thus enhance the patient's immune function. Therefore, it can enhance the antitumor response in whole body.
Humans ; Hyperthermia, Induced ; Mouth Neoplasms ; drug therapy ; T-Lymphocytes, Cytotoxic
9.Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus.
Dong-Sheng ZHANG ; Jia-Wei ZHENG ; Chen-Ping ZHANG ; Zhi-Gang CAI ; Long-Jiang LI ; Gui-Qing LIAO ; Zheng-Jun SHANG ; Mo-Yi SUN ; Zheng-Xue HAN ; Wei SHANG ; Jian MENG ; Zhong-Cheng GONG ; Sheng-Yun HUANG
West China Journal of Stomatology 2020;38(6):603-615
Large general hospitals currently play an increasingly important role in the diagnosis and treatment for acute critical patients and difficult diseases because of the development of dual referral system and hierarchical diagnosis, as well as the formation of medical treatment alliance. Patients with oral cancers are often associated with systemic diseases, which increases the complexity of the condition. Thus, meeting the demand through the traditional single medical model is difficult. As such, a multidisciplinary team (MDT) model has been proposed and has achieved a good clinical effect. To standardize the application of this model, we organized an event in which relevant experts discussed and formulated a consensus to provide standardized suggestions on the MDT process and the diagnosis and treatment of common systemic diseases as reference for clinical practice.
Consensus
;
Humans
;
Mouth Neoplasms/therapy*
;
Patient Care Team
;
Referral and Consultation
10.Combined and sequential treatment of oral and maxillofacial malignancies: an evolving concept and clinical protocol.
Jia-wei ZHENG ; Wei-liu QIU ; Zhi-yuan ZHANG
Chinese Medical Journal 2008;121(19):1945-1952
OBJECTIVETo introduce the concept and rational regimens and present the latest development of combined treatment of oral and maxillofacial malignancies. Data sources The related published literature was searched through the CNKI database and MEDLINE using the terms of oral cancer, oral and maxillofacial malignancies, combined and sequential therapy, multidisciplinary approach. Study selection The available related literature was read and evaluated. Studies that met the inclusion criteria were selected.
RESULTSThe results show that oral and maxillofacial malignancies diagnosed at an early stages (stages I and II) can be well treated with surgery alone and/or radiotherapy with optimal outcome, but advanced or recurrent diseases should be treated with rational combined and sequential treatment modalities. The use of concomitant chemoradiotherapy, taxane-containing, three-drug induction regimens and Cetuximab in combination with chemotherapy or radiotherapy demonstrated favorable results in previously untreated patients with head and neck squamous cell carcinoma.
CONCLUSIONSThe concept of combined and sequential treatment of advanced oral and maxillofacial malignancies should be widely accepted, and the rational regimen for individual and each type of entity should be determined based on the anatomical site and the patient's performance status.
Carcinoma, Squamous Cell ; therapy ; Combined Modality Therapy ; Facial Neoplasms ; therapy ; Humans ; Lymphoma ; therapy ; Maxillary Neoplasms ; therapy ; Melanoma ; therapy ; Mouth Neoplasms ; therapy ; Salivary Gland Neoplasms ; therapy ; Sarcoma ; therapy